Literature DB >> 21702013

Impaired suppression of synovial fluid CD4+CD25- T cells from patients with juvenile idiopathic arthritis by CD4+CD25+ Treg cells.

Susanne Haufe1, Markus Haug, Carsten Schepp, Jasmin Kuemmerle-Deschner, Sandra Hansmann, Nikolaus Rieber, Nikolay Tzaribachev, Toni Hospach, Jan Maier, Guenther E Dannecker, Ursula Holzer.   

Abstract

OBJECTIVE: Natural CD4+CD25+FoxP3+ Treg cells play a crucial role in maintaining immune homeostasis and controlling autoimmunity. In patients with juvenile idiopathic arthritis (JIA), inflammation occurs despite the increased total numbers of Treg cells in the synovial fluid (SF) compared to the peripheral blood (PB). This study was undertaken to investigate the phenotype of CD4+ T cells in PB and SF from JIA patients, the function of synovial Treg cells, and the sensitivity of PB and SF CD4+CD25- effector T cells to the immunoregulatory properties of Treg cells, and to study the suppression of cytokine secretion from SF effector T cells by Treg cells.
METHODS: The phenotypes of effector T cells and Treg cells of PB and SF from JIA patients and healthy donors were determined by flow cytometry. The functionality of isolated Treg cells and effector T cells was quantified in (3) H-thymidine proliferation assays. Cytokine levels were analyzed using Bio-Plex Pro assay.
RESULTS: Compared to PB, SF showed significantly elevated numbers of activated and differentiated CD4+CD45RO+ T cells. Sensitivity of SF effector T cells to the suppressive effects of Treg cells from both PB and SF was impaired, correlating inversely with the expression of CD69 and HLA-DR. However, SF effector T cell cytokine secretion was partly suppressed by SF Treg cells.
CONCLUSION: Our findings indicate that regulation is impaired in the SF of patients with JIA, as shown by the resistance of effector T cells to immunoregulation by functional Treg cells. This resistance of the SF effector T cells might be due to their activated phenotype.
Copyright © 2011 by the American College of Rheumatology.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21702013     DOI: 10.1002/art.30503

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  32 in total

Review 1.  TREG-cell therapies for autoimmune rheumatic diseases.

Authors:  Makoto Miyara; Yoshinaga Ito; Shimon Sakaguchi
Journal:  Nat Rev Rheumatol       Date:  2014-07-01       Impact factor: 20.543

2.  PD-1+CD8+ T cells are clonally expanding effectors in human chronic inflammation.

Authors:  Alessandra Petrelli; Gerdien Mijnheer; David P Hoytema van Konijnenburg; Maria M van der Wal; Barbara Giovannone; Enric Mocholi; Nadia Vazirpanah; Jasper C Broen; Dirkjan Hijnen; Bas Oldenburg; Paul J Coffer; Sebastian J Vastert; Berent J Prakken; Eric Spierings; Aridaman Pandit; Michal Mokry; Femke van Wijk
Journal:  J Clin Invest       Date:  2018-08-02       Impact factor: 14.808

Review 3.  CD8(+) T cells in human autoimmune arthritis: the unusual suspects.

Authors:  Alessandra Petrelli; Femke van Wijk
Journal:  Nat Rev Rheumatol       Date:  2016-06-03       Impact factor: 20.543

Review 4.  Treg cells in rheumatoid arthritis: an update.

Authors:  Faye A H Cooles; John D Isaacs; Amy E Anderson
Journal:  Curr Rheumatol Rep       Date:  2013-09       Impact factor: 4.592

Review 5.  Effector T Cells in Multiple Sclerosis.

Authors:  Belinda J Kaskow; Clare Baecher-Allan
Journal:  Cold Spring Harb Perspect Med       Date:  2018-04-02       Impact factor: 6.915

6.  Immunome perturbation is present in patients with juvenile idiopathic arthritis who are in remission and will relapse upon anti-TNFα withdrawal.

Authors:  Jing Yao Leong; Phyllis Chen; Joo Guan Yeo; Fauziah Ally; Camillus Chua; Sharifah Nur Hazirah; Su Li Poh; Lu Pan; Liyun Lai; Elene Seck Choon Lee; Loshinidevi D/O Thana Bathi; Thaschawee Arkachaisri; Daniel Lovell; Salvatore Albani
Journal:  Ann Rheum Dis       Date:  2019-09-20       Impact factor: 19.103

7.  Interaction with activated monocytes enhances cytokine expression and suppressive activity of human CD4+CD45ro+CD25+CD127(low) regulatory T cells.

Authors:  Gina J Walter; Hayley G Evans; Bina Menon; Nicola J Gullick; Bruce W Kirkham; Andrew P Cope; Frédéric Geissmann; Leonie S Taams
Journal:  Arthritis Rheum       Date:  2013-03

8.  Premature cell senescence and T cell receptor-independent activation of CD8+ T cells in juvenile idiopathic arthritis.

Authors:  Jeffrey A Dvergsten; Robert G Mueller; Patricia Griffin; Sameem Abedin; Allyson Pishko; Joshua J Michel; Margalit E Rosenkranz; Ann M Reed; Daniel A Kietz; Abbe N Vallejo
Journal:  Arthritis Rheum       Date:  2013-08

Review 9.  T cells out of control--impaired immune regulation in the inflamed joint.

Authors:  Ellen J Wehrens; Berent J Prakken; Femke van Wijk
Journal:  Nat Rev Rheumatol       Date:  2013-01       Impact factor: 20.543

10.  Next-Generation Sequencing Reveals Restriction and Clonotypic Expansion of Treg Cells in Juvenile Idiopathic Arthritis.

Authors:  Lauren A Henderson; Stefano Volpi; Francesco Frugoni; Erin Janssen; Susan Kim; Robert P Sundel; Fatma Dedeoglu; Mindy S Lo; Melissa M Hazen; Mary Beth Son; Ronald Mathieu; David Zurakowski; Neng Yu; Tatiana Lebedeva; Robert C Fuhlbrigge; Jolan E Walter; Yu Nee Lee; Peter A Nigrovic; Luigi D Notarangelo
Journal:  Arthritis Rheumatol       Date:  2016-07       Impact factor: 10.995

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.